DiSliceX
SKU: SLI100021 Target: ADAM9, CD63, CD81, CD99, JAM-A
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100009 Target: CD63
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100010 Target: ALPP, CD63, LGALS1, YAP1
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100017 Target: B4GALT1, B7H6, CD166, CD63, CXCR4, EPHA2, FOLR1, IGF-1R, IGFBP7, LGALS1, MSLN
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100013 Target: B7H2, B7H6, BAFF-R, CD10, CD19, CD205, CD21, CD22, CD23, CD27, CD40, CD48, CD70, CD74, CD79B, CXCR5, ICAM-1, NTB-A, PVRIG
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100015 Target: CD147
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100023 Target: CCR8, CD45, LGALS1
Application: Identification of immunohistochemical function
Price: 2 slides $129.00
DiSliceX
SKU: SLI100020 Target: CD63
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100019 Target: AFP, ALB, ASGR1, CD63
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100018 Target: 5T4, DDR1, Her2, LIV-1
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100008 Target: CD45
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100011 Target: B7H5, BST1, CCR2, CD33, CD70, CD93, CHI3L1, TREM2
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100014 Target: ADAM9, CD63
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100024 Target: CD24
Application: Identification of immunohistochemical function
Price: 2 slides $129.00
DiSliceX
SKU: SLI100022 Target: CD63, CSF1R
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100012 Target: CD63
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100003 Target: AXL, CD63, EPCAM, LGALS1
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100007 Target: CD46, CD73, CDH17, CEACAM5, EPCAM, FZD10, GPA33, GUCY2C, HER3
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100005 Target: Nectin-4
Application: IHC
Price: 2 slides $129.00
DiSliceX
SKU: SLI100004 Target: ADAM9, AFP, ALB, ANGPTL3, B7H3, CD112, CD24, CDH6, CLDN6, CLU, CXADR, GPC3, HER3, MSLN, PRLR, SCF
Application: IHC
Price: 2 slides $129.00
Posts found
CDH17 ADCs blooms in 2025 AACR
The 116th AACR Annual Meeting will be held from April 25 to 30, 2025, at [...]
Apr
CD73: A Potential Target in Cancer Immunotherapy
On September 25, 2024, I-Mab announced a strategic collaboration with Sanofi to develop, produce, and [...]
Oct
HER3/ERBB3: Dominating Cancer Therapy with ADCs and Beyond
On September 17, a collaboration between Daiichi Sankyo and Merck announced that patritumab deruxtecan, a [...]
Sep
Research Progress on BCMA-Targeted Therapies in Multiple Myeloma
On August 27, 2024, Legend Biotech’s BCMA CAR-T product, Carvykti® (generic name: ciltacabtagene autoleucel injection), [...]
Sep
Research Progress on Targeting BCMA in Autoimmune Diseases
The B cell maturation antigen (BCMA), a target that gained prominence due to its association [...]
Aug
The Fate of ADAM9 ADCs: What Lies Ahead After AbbVie’s Decision?
In March 2024, AbbVie announced its decision to terminate the development of IMGC936 in collaboration [...]
Aug
CDH6 ADC: Promising Results for Ovarian Cancer Treatment!
In March 2024, a preclinical study titled “Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a [...]
Jul